Akoya Biosciences Inc.

NASDAQ: AKYA · Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM

Akoya Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
79.96M 81.67M 86.81M 93.22M 93.57M 96.63M 91.36M 85M 79.38M 74.86M 69.8M 64.42M 59.6M 54.92M 51.67M 48.15M 43.63M
Cost of Revenue
30.59M 33.79M 38.58M 41.43M 43.06M 42.2M 39.63M 37.64M 33.79M 31.47M 28.23M 25.31M 22.69M 20.7M 19.77M 18.66M 17.02M
Gross Profit
49.37M 47.88M 48.23M 51.79M 50.52M 54.43M 51.73M 47.36M 45.59M 43.39M 41.57M 39.12M 36.91M 34.22M 31.9M 29.48M 26.62M
Operating Income
-38.56M -42.18M -45.29M -48.49M -56.65M -56.82M -65.1M -69.84M -68.06M -66.21M -65.89M -60.34M -49.25M -39.3M -25.67M -18.59M -16.05M
Interest Income
1.88M 2.51M 3.04M 3.59M 3.66M 3.49M 3.14M 2.2M 1.52M 776K 212K 76K 22K n/a n/a n/a n/a
Pretax Income
-47.4M -55.22M -57.84M -60.25M -67.93M -63.28M -71.36M -76.31M -72.91M -70.52M -69.41M -63.18M -51.36M -43.08M -31M -23.67M -22.65M
Net Income
-47.53M -55.37M -57.97M -60.35M -68M -63.32M -71.4M -76.35M -73.04M -70.64M -69.44M -63.18M -51.25M -42.94M -30.96M -23.62M -22.64M
Selling & General & Admin
67.03M 69.32M 72.53M 76.87M 80.49M 82.38M 84.43M 85.34M 83.22M 79.65M 77.75M 71.55M 61.03M 51.02M 38.79M 30.77M 25.81M
Research & Development
19.75M 19.75M 19.99M 20.68M 21.67M 21.89M 23.65M 23.95M 23.27M 23.21M 22.34M 20.87M 18.22M 15.7M 12.67M 10.95M 10.42M
Other Expenses
999K 838K 849K -263K -456K 1.68M 3.44M 5.44M 7.16M 6.73M 4.81M 2.87M 1.2M -410K -101K 82K 78K
Operating Expenses
87.71M 89.99M 93.44M 97.56M 104M 108.09M 113.66M 116.67M 113.65M 109.6M 106.44M 98.21M 84.51M 71.44M 55.83M 45.83M 40.16M
Interest Expense
10.31M 10.43M 10.14M 9.75M 9.32M 8.76M 8.31M 7.18M 5.86M 4.55M 3.55M 3.21M 3.11M 3.12M 3.02M 2.94M 2.84M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
118.3M 123.78M 132.02M 138.99M 147.06M 150.29M 153.29M 154.31M 147.44M 141.07M 134.67M 123.51M 107.2M 92.14M 75.6M 64.49M 57.18M
Income Tax Expense
35K 146K 132K 73K 44K 10K 6K 42K 130K 123K 32K n/a -112K -140K -49K -47K -2K
Shares Outstanding (Basic)
49.66M 49.56M 49.5M 49.42M 49.19M 49.09M 48.98M 40.64M 38.33M 38M 37.9M 37.61M 37.46M 37.25M 37.16M 29.97M 35.69M
Shares Outstanding (Diluted)
49.66M 49.56M 49.5M 49.42M 49.19M 49.09M 48.98M 40.64M 38.33M 38M 37.9M 37.61M 37.46M 37.25M 37.16M 29.97M 35.69M
EPS (Basic)
-0.97 -1.13 -1.18 -1.23 -1.47 -1.48 -1.76 -1.97 -1.93 -1.88 -1.85 -1.69 -1.41 -1.2 -0.89 -0.73 -0.7
EPS (Diluted)
-0.97 -1.13 -1.18 -1.23 -1.47 -1.48 -1.76 -1.97 -1.93 -1.88 -1.85 -1.69 -1.41 -1.2 -0.89 -0.73 -0.7
EBITDA
-31.79M -37.14M -39.79M -41.84M -49.79M -45.63M -54.36M -61.08M -59.4M -58.81M -59.23M -54.05M -42.88M -35.2M -23.58M -16.6M -15.88M
EBIT
-23.98M -44.79M -47.7M -50.5M -58.61M -54.52M -63.05M -69.13M -67.06M -65.96M -65.86M -59.98M -48.25M -39.96M -27.99M -20.73M -19.81M
Depreciation & Amortization
5.84M 7.89M 7.91M 8.66M 8.82M 8.89M 8.69M 8.05M 7.65M 7.15M 6.62M 5.93M 5.37M 4.76M 4.41M 4.13M 3.92M